Stroke Clinical Trials in New York, New York

19 studies are recruiting for stroke in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

   This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limi…

   Stage

   Phase 2

   Ages

   18 to 90

   Site

   Northwell Health Physician Partners - Neurology at Lenox Hill, New York, New York

   Locations

   86 in total

   Run by

   DiaMedica Therapeutics Inc

   See if you can join NCT05065216 on ClinicalTrials.gov

2. Telerehabilitation In The Home After Stroke

   The purpose of this research study is to evaluate whether telerehabilitation targeting arm movement, when added to usual care, improves arm function and reduces global disability after stroke, compared to usual care alone. Patients with arm weakness due to stroke that happened in the past 90-150 da…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Icahn School of Medicine at Mount Sinai, New York, New York

   Locations

   27 in total

   Run by

   University of California, Los Angeles

   See if you can join NCT06682429 on ClinicalTrials.gov

3. Treatment With Endovascular Intervention for STroke Patients With Existing Disability

   TESTED will compare the risks and benefits of endovascular thrombectomy (EVT) to medical management (no EVT) in ischemic stroke patients who have a blockage in one of the large blood vessels in the brain and have a moderate-to-severe disability prior to their stroke.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Icahn School of Medicine at Mount Sinai, New York, New York

   Locations

   35 in total

   Run by

   University of Cincinnati

   See if you can join NCT05911568 on ClinicalTrials.gov

4. Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

   VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, tra…

   Stage

   Not phased

   Ages

   18 and older

   Site

   The Mount Sinai Hospital, New York, New York

   Locations

   45 in total

   Run by

   Yale University

   See if you can join NCT05338697 on ClinicalTrials.gov

5. A Digital Intervention for Post-Stroke Depression and Executive Dysfunction

   Individuals with stroke commonly experience both depression and cognitive difficulties. The goal of this study is to evaluate the efficacy of a treatment that combines a digital therapeutic (an iPad-based cognitive training program) with learning cognitive strategies. The hypotheses are that this t…

   Stage

   Phase 2

   Ages

   50 to 79

   Site

   Weill Cornell Medical Center, New York, New York

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT05507138 on ClinicalTrials.gov

6. Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation

   Patients with atrial fibrillation (AF) who have had a prior stroke are at very high risk of recurrent ischemic stroke. About 40% of these strokes are due to large emboli which result in large cerebral vessel occlusion (LVO). This randomized control trial aims to address this unmet need by testing w…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Weill Cornell Medical Center, New York, New York

   Locations

   21 in total

   Run by

   Javelin Medical

   See if you can join NCT05723926 on ClinicalTrials.gov

7. Cognition and Imaging With Tigertriever

   The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.

   Stage

   Not phased

   Ages

   18 to 75

   Site

   Westchester Medical Center, New York, New York

   Locations

   3 in total

   Run by

   Rapid Medical

   See if you can join NCT05531461 on ClinicalTrials.gov

8. Music Listening for Mental Health Recovery After Stroke

   This study aims to explore whether listening to music intentionally can support the mental health of people recovering from a stroke. The question the investigators aim to answer is: Can intentional music listening improve emotional well-being in stroke survivors? And if so, what kinds of changes m…

   Stage

   Not phased

   Ages

   50 to 90

   Site

   New York University, New York, New York

   Run by

   New York University

   See if you can join NCT07127159 on ClinicalTrials.gov

9. Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

   The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.

   Stage

   Not phased

   Ages

   18 to 100

   Site

   Icahn School of Medicine at Mount Sinai, New York, New York

   Locations

   20 in total

   Run by

   Zeenat Qureshi Stroke Institute

   See if you can join NCT06402968 on ClinicalTrials.gov

10. Mobile Cognitive Behavioral Therapy for Stroke

    This study aims to assess the feasibility and acceptability of "MAYA", a mobile cognitive behavioral therapy app for anxiety and mood disorders, in adults who have had a stroke.

    Stage

    Not phased

    Ages

    40 to 79

    Site

    Weill Cornell Medicine, New York, New York

    Run by

    Weill Medical College of Cornell University

    See if you can join NCT06689878 on ClinicalTrials.gov

11. GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

    This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.

    Stage

    Not phased

    Ages

    18 to 70

    Site

    Columbia University Medical Center/NYPH, New York, New York

    Locations

    45 in total

    Run by

    W.L.Gore & Associates

    See if you can join NCT03821129 on ClinicalTrials.gov

12. Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients

    The purpose of this research is to evaluate a new investigational device for the diagnosis of stroke, the EMVision emu™ Brain Scanner. Stroke is the result of a blood clot stopping the normal flow of blood in the brain (ischaemic stroke) or a breakage in a blood vessel causing bleeding in the brain…

    Stage

    Not phased

    Ages

    22 and older

    Site

    Mount Sinai West, New York, New York

    Locations

    8 in total

    Run by

    EMVision Medical Devices Ltd

    See if you can join NCT06999122 on ClinicalTrials.gov

13. Pilot/Pivotal Study of DBS+Rehab After Stroke

    The RESTORE Stroke Study will evaluate the safety and effectiveness of DBS+Rehab for treating arm weakness and reduced function after a stroke.

    Stage

    Not phased

    Ages

    21 and older

    Site

    NYU Langone Health, New York, New York

    Locations

    10 in total

    Run by

    Enspire DBS Therapy, Inc.

    See if you can join NCT05701280 on ClinicalTrials.gov

14. Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

    CAPTIVA-MRI is an observational multimodal MR imaging study that is ancillary to the CAPTIVA trial [a 3-arm, double-blind Phase III trial conducted at approximately 115 StrokeNet sites randomizing patients with stroke attributed to 70-99% intracranial atherosclerotic stenosis (ICAS) to aspirin plus…

    Stage

    Not phased

    Ages

    18 and older

    Site

    NYP Columbia University Medical Center, New York, New York

    Locations

    28 in total

    Run by

    Yale University

    See if you can join NCT05907629 on ClinicalTrials.gov

15. Genetic and Environmental Risk Factors for Hemorrhagic Stroke

    The purpose of this study is to find risk factors for hemorrhagic stroke.

    Stage

    Not phased

    Ages

    18 and older

    Site

    Columbia University, New York, New York

    Locations

    7 in total

    Run by

    State University of New York at Buffalo

    See if you can join NCT00682695 on ClinicalTrials.gov

16. Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

    The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated c…

    Stage

    Phase 3

    Ages

    18 and older

    Site

    Columbia University Medical Center, New York, New York

    Locations

    106 in total

    Run by

    Icahn School of Medicine at Mount Sinai

    See if you can join NCT04045665 on ClinicalTrials.gov

17. MyHand 2: An Active Hand Orthosis for Stroke Patients

    This study is designed to further develop and test the hardware and software components of the MyHand device based on user feedback and results from our pilot study. The goal is to refine the device so that is more effective and easier for stroke patients to use to increase their hand function.

    Stage

    Not phased

    Ages

    18 and older

    Site

    Columbia University Irving Medical Center, New York, New York

    Run by

    Columbia University

    See if you can join NCT04436042 on ClinicalTrials.gov

18. SDOH-Homecare Intervention Focus Team (SHIFT) Trial to Improve Stroke Outcomes

    Primary Goal: To test the hypothesis that among stroke patients 18-75 years with ≥3 SDOH risk factors, SHIFT will improve: (1) functional outcomes as measured by the SIS (Primary Outcome), (2) physiological outcomes as measured by changes in blood pressure and cognition, (secondary outcomes) and (3…

    Stage

    Not phased

    Ages

    18 to 75

    Site

    Columbia University Medical Center, New York, New York

    Run by

    Columbia University

    See if you can join NCT06397937 on ClinicalTrials.gov

19. Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia

    The purpose of this study is to assess changes in language abilities of participants with chronic, post-stroke aphasia following an 8-week therapy period combined with brain stimulation. The investigators use a stimulation method called transcranial direct current stimulation (tDCS). The investigat…

    Stage

    Not phased

    Ages

    21 to 80

    Site

    City University of New York, New York, New York

    Run by

    City University of New York

    See if you can join NCT04142866 on ClinicalTrials.gov